Skip to content

The application of Zishen Yutai Pill in aged women undergoing in vitro fertilization-embryo transfer: a multi-center double-blind randomized controlled trial

The application of Zishen Yutai Pill in aged women undergoing in vitro fertilization-embryo transfer: a multi-center double-blind randomized controlled trial

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPR-17010630
Enrollment
Unknown
Registered
2017-02-14
Start date
2019-01-09
Completion date
Unknown
Last updated
2019-02-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infertility

Interventions

Sponsors

Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
35 Years to 42 Years

Inclusion criteria

Inclusion criteria: (1) infertile women aged =35 and =42 years;; (2) intend to undergo IVF-ET (long or antagonist protocol); (3) BMI<28kg/m2; (4) bilateral ovaries exist; (5) patients who voluntarily signed the informed consent and agreed to be followed up as required by the study protocol.

Exclusion criteria

Exclusion criteria: (1) repeatedly inplanting failure (previous three times or more IVF/ICSI - ET failure); (2) adenomyosis, uterine line constricted by uterine fibroid; (3) untreated bilateral hydrosalpinx; (4) not cure endometrial diseases; (5) with disease not suitable for undergoing assisted reproductive technology or at the present not suitable for pregnancy; (6) patients who have taken traditional Chinese medicine or Chinese patent medicine for infertility treatment in the past one month(30 days).

Design outcomes

Primary

MeasureTime frame
clinical pregnancy rate;live birth rate;

Secondary

MeasureTime frame
estrodiol;number of oocyte retrieved;The fertilized egg number;Number of cleavage;cleavage rate;available number of embryos;available number of embryos rate;High quality embryo number;High quality embryo number rate;abortion rate;weight of newborn;length of newborn;Congenital malformation rate;Implantation rate;rate of retrieved oocytes;

Countries

China

Contacts

Public ContactYu Li

Sun Yat-sen Memorial Hospital

liyuliyu0922@163.com+86 13660141860

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026